Your search returned 719 results.

Results
	101.	Risk of elevated transaminases in non-small cell lung cancer (NSCLC) patients treated with erlotinib, gefitinib and afatinib: a meta-analysis. [electronic resource] by Abdel-Rahman, Omar Ahmed, Hoda ElHalawani, Hesham Producer: 20180822 In: Expert review of respiratory medicine vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	102.	Afatinib with subsequent surgery in stage III NSCLC with EGFR mutation: Lessons learned from two clinical experiences. [electronic resource] by Mazzoni, Francesca Petreni, Paolo Perna, Marco Scotti, Vieri Bongiolatti, Stefano Livi, Lorenzo Di Costanzo, Francesco Voltolini, Luca Producer: 20190819 In: Tumori vol. 104 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	103.	Irreversible kinase inhibitors gain traction. [electronic resource] by Sanderson, Katharine Producer: 20131112 In: Nature reviews. Drug discovery vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	104.	Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatin. [electronic resource] by Brands, Roman C Müller-Richter, Urs D A De Donno, Francesco Seher, Axel Mutzbauer, Grit Linz, Christian Kübler, Alexander C Hartmann, Stefan Producer: 20161226 In: Molecular medicine reports vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	105.	A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors. [electronic resource] by Spicer, James Irshad, Sheeba Ang, Joo Ern Enting, Deborah Kristeleit, Rebecca Uttenreuther-Fischer, Martina Pemberton, Karine Pelling, Katy Schnell, David de Bono, Johann Producer: 20170602 In: Cancer chemotherapy and pharmacology vol. 79 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	106.	Afatinib for an EGFR exon 20 insertion mutation: A case report of progressive stage IV metastatic lung adenocarcinoma with 54 months' survival. [electronic resource] by Chan, Raymond Tsz-Tong Producer: 20180521 In: Asia-Pacific journal of clinical oncology vol. 14 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	107.	Afatinib (BIBW 2992) development in non-small-cell lung cancer. [electronic resource] by Hirsh, Vera Producer: 20111028 In: Future oncology (London, England) vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	108.	Therapeutic Changes in Bilateral Choroidal Metastasis from Non-Small Cell Lung Cancer with Response to Afatinib: A Case Report. [electronic resource] by Zhou, Han Peng Tanaka, Rie Tsuji, Hideki Producer: 20210716 In: Ocular immunology and inflammation vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	109.	What next? Preferably development of drugs that are no longer transported by the ABCB1 and ABCG2 efflux transporters. [electronic resource] by van Hoppe, Stéphanie Schinkel, Alfred H Producer: 20180702 In: Pharmacological research vol. 123 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	110.	Cardiac Toxicity From Afatinib in EGFR-Mutated NSCLC: A Rare But Possible Side Effect. [electronic resource] by Nuvola, Giacomo Dall'Olio, Filippo Gustavo Melotti, Barbara Sperandi, Francesca Ardizzoni, Andrea Producer: 20200625 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	111.	Inhibition of proliferation and induction of apoptosis in RB116 retinoblastoma cells by afatinib treatment. [electronic resource] by Zhan, Wei-Jiao Zhu, Jian-Feng Wang, Long-Mei Producer: 20170206 In: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	112.	Cryoprotectant toxicity in Caenorhabditis elegans. [electronic resource] by Tedesco, Patricia M Schumacher, Garrett J Johnson, Thomas E Producer: 20191218 In: Cryobiology vol. 86 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	113.	EGFR L861Q and CDK4 amplification responding to afatinib combined with palbociclib treatment in a patient with advanced lung squamous cell carcinoma. [electronic resource] by Jiang, Hui Luo, Ningning Zhang, Xing Song, Chao Zang, Jianhua Producer: 20210621 In: Lung cancer (Amsterdam, Netherlands) vol. 145 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	114.	BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumors. [electronic resource] by Minkovsky, Natalie Berezov, Alan Producer: 20090209 In: Current opinion in investigational drugs (London, England : 2000) vol. 9 Availability: No items available. Save to lists Add to cart (remove)
	115.	Afatinib monotherapy in EGFR-mutant lung adenocarcinoma. [electronic resource] by Gilbert, Judith A Producer: 20130930 In: The Lancet. Oncology vol. 14 Availability: No items available. Save to lists Add to cart (remove)
	116.	Afatinib with concurrent radiotherapy in a patient with metastatic non-small cell lung cancer. [electronic resource] by Atmaca, Akin Al-Batran, Salah-Eddin Allgäuer, Michael Jäger, Elke Producer: 20150114 In: Oncology research and treatment vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	117.	Patients with exon 19 deletion were associated with longer progression-free survival compared to those with L858R mutation after first-line EGFR-TKIs for advanced non-small cell lung cancer: a meta-analysis. [electronic resource] by Zhang, Yaxiong Sheng, Jin Kang, Shiyang Fang, Wenfeng Yan, Yue Hu, Zhihuang Hong, Shaodong Wu, Xuan Qin, Tao Liang, Wenhua Zhang, Li Producer: 20150528 In: PloS one vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	118.	Melanoma-associated antigen A11 reduces erlotinib and afatinib efficacy in head and neck cancer. [electronic resource] by Hartmann, Stefan Zwick, Leonie Maurus, Katja Fuchs, Andreas R Brands, Roman C Seher, Axel Kübler, Alexander C Müller-Richter, Urs D A Producer: 20181211 In: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	119.	Label-free LC-MS analysis of HER2+ breast cancer cell line response to HER2 inhibitor treatment. [electronic resource] by Di Luca, Alessio Henry, Michael Meleady, Paula O'Connor, Robert Producer: 20160309 In: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	120.	Afatinib in Treatment-Naive Patients With EGFR-Mutated Lung Adenocarcinoma With Brain Metastasis: A Case Series. [electronic resource] by Li, Shih-Hong Hsieh, Meng-Heng Fang, Yueh-Fu Producer: 20160119 In: Medicine vol. 94 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 719 results.